IO2 INTERVENTIONAL & IMMUNO-ONCOLOGY

BTG International Limited

Application Filed: 2018-07-13
Trademark Application Details
Trademark Logo IO2 INTERVENTIONAL & IMMUNO-ONCOLOGY

The mark consists of the words "INTERVENTIONAL &" above the word "IMMUNO-ONCOLOGY" to the right of a stylized depiction of "IO" with the number "2" in superscript to the right of "IO" in a box.

Mark For: IO2 INTERVENTIONAL & IMMUNO-ONCOLOGY™ trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolization; pharmaceutical preparations and substances for embolization of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical purposes; transarterial chemoembolization pharmaceutical preparations, vaccines and sera; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances for medical purposes; radiopharmaceuticals; therapeutic agents for delivery of radioactive material to target sites within the body; radioactive substances for medical purposes, namely, microscopic radioactive beads for treatment of cancerous tumours, microscopic glass beads incorporating radioactive material for treatment of cancerous tumours, and radioactive glass beads; pharmaceutical preparations for use in chemotherapy. [all]

>Color is not claimed as a feature of the mark. The mark consists of the words "INTERVENTIONAL &" above the word "IMMUNO-ONCOLOGY" to the right of a stylized depiction of "IO" with the number "2" in superscript to the right of "IO" in a box.

Status

2021-07-14 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88037659
Mark Literal ElementsIO2 INTERVENTIONAL & IMMUNO-ONCOLOGY
Mark Drawing Type3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark TypeTRADEMARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationTMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED 2019-12-05
Basis44(e)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseNo
Filed ITUYes
44D FiledYes
44E CurrentYes
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameJonathan A. Hyman
Attorney Docket NumberRJENK70.044T
Law Office AssignedL30
Employee NameGOLDEN, LAURA DAWN

Timeline

2018-07-13Application Filed
2018-11-02Trademark Registered
2018-11-20Location: TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED
2018-11-20Status: Live/Pending
2019-01-03Transaction Date
2019-12-05Location: TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED
2021-06-09Status: Suspension check completed. Application remains suspended.

Trademark Parties (Applicants & Owners)

Party: BTG International Limited
Address5 Fleet Place London UNITED KINGDOM EC4M7RD
Legal Entity TypePrivate Limited Company
Legal Entity StateUNITED KINGDOM

Design Search Codes

26.09.25Squares with curved sides
260921Squares that are completely or partially shaded
260925Squares with curved sides

Attorney of Record

JONATHAN A. HYMAN
KNOBBE MARTENS OLSON & BEAR LLP
2040 MAIN STREET, 14TH FLOOR
IRVINE, CA 92614

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolization; pharmaceutical preparations and substances for embolization of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical purposes; transarterial chemoembolization pharmaceutical preparations, vaccines and sera; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances for medical purposes; radiopharmaceuticals; therapeutic agents for delivery of radioactive material to target sites within the body; radioactive substances for medical purposes, namely, microscopic radioactive beads for treatment of cancerous tumours, microscopic glass beads incorporating radioactive material for treatment of cancerous tumours, and radioactive glass beads; pharmaceutical preparations for use in chemotherapy
IC 010. US 026 039 044. G & S: Surgical apparatus and instruments; medical apparatus and instruments for use in the diagnosis and treatment of cancer; Surgical and medical apparatus and instruments, namely, drug delivery systems; apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems comprising surgical and medical instruments for embolisation; drug delivery embolisation systems; drug delivery apparatus and instruments comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; implantable radiation therapy devices, namely, microscopic glass beads incorporating radioactive material or containing radioactive material and administered surgically for treatment of cancerous tumours, and radioactive glass beads administered for treatment of cancerous tumours; surgical and medical apparatus and instruments for use in the circulatory system; needles for medical use, namely, cannula needles; medical devices for performing cryotherapy, namely, cryosurgical probes and cryoablation needles used for the minimally invasive cryoablation of cancerous tissues; medical apparatus consisting of treatment probes and high pressure valves used for heat or freeze treatment; surgical, medical and medical diagnostic devices, apparatus and instruments for use in cryoablation, and the treatment of prostate cancer, kidney or renal tumours, and benign prostatic hyperplasia (BPH); medical devices used to deliver heat to target sites using electrical current through needles; medical devices to deliver cryogen gas for freezing and either cryogen gas or electrical current for heating; medical devices for ablating human and animal tissue using microwave energy; medical devices for treating cancerous and benign tissue using microwave energy; replacement and structural parts for all of the aforesaid goods

International Codes:5
U.S. Codes:006,018,044,046,051,052
International Codes:10
U.S. Codes:026,039,044
Type CodeType
PM0001IO TWO INTERVENTIONAL AND IMMUNO-ONCOLOGY

Trademark Filing History

DescriptionDateProceeding Number
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED2021-06-09
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED2020-12-09
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS2020-08-30
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2020-08-30
TEAS CHANGE OF OWNER ADDRESS RECEIVED2020-08-30
TEAS CHANGE OF CORRESPONDENCE RECEIVED2020-08-30
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2020-08-30
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED2020-08-3088888
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED2020-06-09
SUSPENSION LETTER WRITTEN2019-12-0590286
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED2019-12-056332
LETTER OF SUSPENSION E-MAILED2019-12-056332
TEAS/EMAIL CORRESPONDENCE ENTERED2019-12-0488889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-12-03
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-12-0388889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2019-07-026325
NON-FINAL ACTION WRITTEN2019-07-0290286
NON-FINAL ACTION E-MAILED2019-07-026325
TEAS/EMAIL CORRESPONDENCE ENTERED2019-05-2170468
CORRESPONDENCE RECEIVED IN LAW OFFICE2019-05-2170468
ASSIGNED TO LIE2019-05-1970468
TEAS RESPONSE TO OFFICE ACTION RECEIVED2019-05-10
NOTIFICATION OF NON-FINAL ACTION E-MAILED2018-11-206325
NON-FINAL ACTION WRITTEN2018-11-2090286
NON-FINAL ACTION E-MAILED2018-11-206325
ASSIGNED TO EXAMINER2018-10-3190286
TEAS VOLUNTARY AMENDMENT RECEIVED2018-07-19
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED2018-07-1988889
NOTICE OF DESIGN SEARCH CODE E-MAILED2018-07-19
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-07-18
NEW APPLICATION ENTERED IN TRAM2018-07-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed